Literature DB >> 33399825

Using Prediction Models to Reduce Persistent Racial and Ethnic Disparities in the Draft 2020 USPSTF Lung Cancer Screening Guidelines.

Rebecca Landy1, Corey D Young2, Martin Skarzynski1, Li C Cheung1, Christine D Berg1, M Patricia Rivera3, Hilary A Robbins4, Anil K Chaturvedi1, Hormuzd A Katki1.   

Abstract

We examined whether draft 2020 United States Preventive Services Task Force (USPSTF) lung cancer screening recommendations "partially ameliorate racial disparities in screening eligibility" compared with the 2013 guidelines, as claimed. Using data from the 2015 National Health Interview Survey, USPSTF-2020 increased eligibility by similar proportions for minorities (97.1%) and Whites (78.3%). Contrary to the intent of USPSTF-2020, the relative disparity (differences in percentages of model-estimated gainable life-years from National Lung Screening Trial-like screening by eligible Whites vs minorities) actually increased from USPSTF-2013 to USPSTF-2020 (African Americans: 48.3%-33.4% = 15.0% to 64.5%-48.5% = 16.0%; Asian Americans: 48.3%-35.6% = 12.7% to 64.5%-45.2% = 19.3%; Hispanic Americans: 48.3%-24.8% = 23.5% to 64.5%-37.0% = 27.5%). However, augmenting USPSTF-2020 with high-benefit individuals selected by the Life-Years From Screening with Computed Tomography (LYFS-CT) model nearly eliminated disparities for African Americans (76.8%-75.5% = 1.2%) and improved screening efficiency for Asian and Hispanic Americans, although disparities were reduced only slightly (Hispanic Americans) or unchanged (Asian Americans). The draft USPSTF-2020 guidelines increased the number of eligible minorities vs USPSTF-2013 but may inadvertently increase racial and ethnic disparities. LYFS-CT could reduce disparities in screening eligibility by identifying ineligible people with high predicted benefit regardless of race and ethnicity. Published by Oxford University Press 2021. This work is written by US Government employees and is in the public domain in the US.

Entities:  

Mesh:

Year:  2021        PMID: 33399825      PMCID: PMC8562965          DOI: 10.1093/jnci/djaa211

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  14 in total

1.  The Patient Perspective on Lung Cancer Screening and Health Disparities.

Authors:  Andrea K Borondy Kitts
Journal:  J Am Coll Radiol       Date:  2019-04       Impact factor: 5.532

2.  Identifying Patients for Whom Lung Cancer Screening Is Preference-Sensitive: A Microsimulation Study.

Authors:  Tanner J Caverly; Pianpian Cao; Rodney A Hayward; Rafael Meza
Journal:  Ann Intern Med       Date:  2018-05-29       Impact factor: 25.391

3.  Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening.

Authors:  Hormuzd A Katki; Stephanie A Kovalchik; Christine D Berg; Li C Cheung; Anil K Chaturvedi
Journal:  JAMA       Date:  2016-06-07       Impact factor: 56.272

4.  Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:  Virginia A Moyer
Journal:  Ann Intern Med       Date:  2014-03-04       Impact factor: 25.391

5.  Evaluation of USPSTF Lung Cancer Screening Guidelines Among African American Adult Smokers.

Authors:  Melinda C Aldrich; Sarah F Mercaldo; Kim L Sandler; William J Blot; Eric L Grogan; Jeffrey D Blume
Journal:  JAMA Oncol       Date:  2019-09-01       Impact factor: 31.777

6.  Defining Equity in Eligibility for Cancer Screening.

Authors:  Hilary A Robbins; Mattias Johansson
Journal:  JAMA Oncol       Date:  2020-01-01       Impact factor: 31.777

7.  Risk-Targeted Lung Cancer Screening: A Cost-Effectiveness Analysis.

Authors:  Vaibhav Kumar; Joshua T Cohen; David van Klaveren; Djøra I Soeteman; John B Wong; Peter J Neumann; David M Kent
Journal:  Ann Intern Med       Date:  2018-01-02       Impact factor: 25.391

8.  Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival.

Authors:  Ahmedin Jemal; Elizabeth M Ward; Christopher J Johnson; Kathleen A Cronin; Jiemin Ma; Blythe Ryerson; Angela Mariotto; Andrew J Lake; Reda Wilson; Recinda L Sherman; Robert N Anderson; S Jane Henley; Betsy A Kohler; Lynne Penberthy; Eric J Feuer; Hannah K Weir
Journal:  J Natl Cancer Inst       Date:  2017-09-01       Impact factor: 13.506

9.  A Comparative Modeling Analysis of Risk-Based Lung Cancer Screening Strategies.

Authors:  Kevin Ten Haaf; Mehrad Bastani; Pianpian Cao; Jihyoun Jeon; Iakovos Toumazis; Summer S Han; Sylvia K Plevritis; Erik F Blom; Chung Yin Kong; Martin C Tammemägi; Eric J Feuer; Rafael Meza; Harry J de Koning
Journal:  J Natl Cancer Inst       Date:  2020-05-01       Impact factor: 13.506

10.  Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society Statement.

Authors:  M Patricia Rivera; Hormuzd A Katki; Nichole T Tanner; Matthew Triplette; Lori C Sakoda; Renda Soylemez Wiener; Roberto Cardarelli; Lisa Carter-Harris; Kristina Crothers; Joelle T Fathi; Marvella E Ford; Robert Smith; Robert A Winn; Juan P Wisnivesky; Louise M Henderson; Melinda C Aldrich
Journal:  Am J Respir Crit Care Med       Date:  2020-10-01       Impact factor: 21.405

View more
  15 in total

1.  Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data.

Authors:  Randi M Williams; Tengfei Li; George Luta; Min Qi Wang; Lucile Adams-Campbell; Rafael Meza; Martin C Tammemägi; Kathryn L Taylor
Journal:  Cancer       Date:  2022-02-24       Impact factor: 6.860

Review 2.  Immune response and inflammation in cancer health disparities.

Authors:  Maeve Kiely; Brittany Lord; Stefan Ambs
Journal:  Trends Cancer       Date:  2021-12-27

3.  Evaluating Eligibility of US Black Women Under USPSTF Lung Cancer Screening Guidelines.

Authors:  Alexandra L Potter; Chi-Fu Jeffrey Yang; Kirsten M Woolpert; Thrusha Puttaraju; Kei Suzuki; Julie R Palmer
Journal:  JAMA Oncol       Date:  2022-01-01       Impact factor: 31.777

4.  A Randomized Trial of Telephone-Based Smoking Cessation Treatment in the Lung Cancer Screening Setting.

Authors:  Kathryn L Taylor; Randi M Williams; Tengfei Li; George Luta; Laney Smith; Kimberly M Davis; Cassandra A Stanton; Raymond Niaura; David Abrams; Tania Lobo; Jeanne Mandelblatt; Jinani Jayasekera; Rafael Meza; Jihyoun Jeon; Pianpian Cao; Eric D Anderson
Journal:  J Natl Cancer Inst       Date:  2022-10-06       Impact factor: 11.816

5.  Improved motivation and readiness to quit shortly after lung cancer screening: Evidence for a teachable moment.

Authors:  Randi M Williams; Marisa Cordon; Ellie Eyestone; Laney Smith; George Luta; Brady J McKee; Shawn M Regis; David B Abrams; Raymond S Niaura; Cassandra A Stanton; Vicky Parikh; Kathryn L Taylor
Journal:  Cancer       Date:  2022-02-10       Impact factor: 6.921

6.  Predictors of attrition in a smoking cessation trial conducted in the lung cancer screening setting.

Authors:  Emily Kim; Randi M Williams; Ellie Eyestone; Marisa Cordon; Laney Smith; Kimberly Davis; George Luta; Eric D Anderson; Brady McKee; Juan Batlle; Michael Ramsaier; Judith Howell; Vicky Parikh; Maria Geronimo; Cassandra Stanton; Raymond Niaura; David Abrams; Kathryn L Taylor
Journal:  Contemp Clin Trials       Date:  2021-05-06       Impact factor: 2.261

7.  Disparities in Lung Cancer Screening in Puerto Rico: A United States Colony with Unequal Benefits.

Authors:  Coral Olazagasti; Nagashree Seetharamu
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

8.  Association of computed tomography screening with lung cancer stage shift and survival in the United States: quasi-experimental study.

Authors:  Alexandra L Potter; Allison L Rosenstein; Mathew V Kiang; Shivani A Shah; Henning A Gaissert; David C Chang; Florian J Fintelmann; Chi-Fu Jeffrey Yang
Journal:  BMJ       Date:  2022-03-30

9.  Inaccuracies in electronic health records smoking data and a potential approach to address resulting underestimation in determining lung cancer screening eligibility.

Authors:  Polina V Kukhareva; Tanner J Caverly; Haojia Li; Hormuzd A Katki; Li C Cheung; Thomas J Reese; Guilherme Del Fiol; Rachel Hess; David W Wetter; Yue Zhang; Teresa Y Taft; Michael C Flynn; Kensaku Kawamoto
Journal:  J Am Med Inform Assoc       Date:  2022-04-13       Impact factor: 7.942

10.  Reducing Disparities in Lung Cancer Screening: It's Not So Black and White.

Authors:  Stacey A Fedewa; Gerard A Silvestri
Journal:  J Natl Cancer Inst       Date:  2021-11-02       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.